Alzheimer's disease(AD)and Parkinson's disease(PD)are two of the most prevalent types of degenerative neurological diseases.The biological activities of marine glycoconjugates, such as antioxidant, anticoagulant, antitumor, hypolipidemic, and antibacterial properties, have gained significant attention.There is a growing body of research exploring the role of marine glycoconjugates in AD and PD.This review aims to summarize the recent progress in the use of marine glycoconjugates for the prevention and treatment of AD and PD, providing new insights for future approaches in managing these diseases.

Alzheimer's disease(AD)and Parkinson's disease(PD)are two of the most prevalent types of degenerative neurological diseases.The biological activities of marine glycoconjugates, such as antioxidant, anticoagulant, antitumor, hypolipidemic, and antibacterial properties, have gained significant attention.There is a growing body of research exploring the role of marine glycoconjugates in AD and PD.This review aims to summarize the recent progress in the use of marine glycoconjugates for the prevention and treatment of AD and PD, providing new insights for future approaches in managing these diseases.